Literature DB >> 11480848

Hyperactivity in a mouse model of the antiphospholipid syndrome.

A Katzav1, C G Pick, A D Korczyn, E Oest, M Blank, Y Shoenfeld, J Chapman.   

Abstract

In the antiphospholipid syndrome (APS), antibodies to a complex of phospholipids and beta2-glycoprotein I (beta2-GPI) are associated with recurrent thromboembolic events, spontaneous abortions, thrombocytopenia and central nervous system (CNS) disturbances. Animals immunized with beta2-GPI develop the systemic manifestations of APS but the involvement of the (CNS) in these animals has not been studied. The objective of the present study was to examine mice with induced experimental APS for behavioral changes. Female Balb/C mice were immunized once with beta2-GPI in complete Freund's adjuvant (CFA) or with CFA alone. Four months after immunization the mice were tested in the staircase apparatus and the following two variables were measured: (1) number of rears: and (2) number of stairs climbed by the mice. Immunization with beta2-GPI resulted in elevated levels of circulating anti-negatively charged phospholipids and anti-beta2-GPI antibodies. The APS mice exhibited hyperactive behavior as reflected by more frequent rears (P < 0.023) and higher number of stairs climbed (P < 0.019) by the mice in 3 min. This simple test demonstrated that experimental APS animals are significantly hyperactive and may serve as a marker for CNS involvement in this model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11480848     DOI: 10.1191/096120301678416060

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  14 in total

Review 1.  Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome.

Authors:  Cécile M Yelnik; Elizabeth Kozora; Simone Appenzeller
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

2.  Diffusion tensor imaging in patients with obstetric antiphospholipid syndrome without neuropsychiatric symptoms.

Authors:  Fabricio R Pereira; Francesco Macri; Marcel P Jackowski; William J Kostis; Jean-Christophe Gris; Jean-Paul Beregi; Choukri Mekkaoui
Journal:  Eur Radiol       Date:  2015-07-23       Impact factor: 5.315

Review 3.  Immunoglobulin-mediated neuro-cognitive impairment: new data and a comprehensive review.

Authors:  Assaf Menachem; Joab Chapman; Yael Deri; Chaim G Pick; Aviva Katzav
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 4.  Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  José Fidel Baizabal-Carvallo; Cecilia Bonnet; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2013-04-13       Impact factor: 3.575

5.  Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome.

Authors:  R Weiss; A Bitton; L Nahary; M T Arango; I Benhar; M Blank; Y Shoenfeld; J Chapman
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

6.  The pathogenesis of neural injury in animal models of the antiphospholipid syndrome.

Authors:  Aviva Katzav; Yehuda Shoenfeld; Joab Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

7.  Significant changes in the levels of secreted cytokines in brains of experimental antiphospholipid syndrome mice.

Authors:  Assaf Menachem; Joab Chapman; Aviva Katzav
Journal:  Autoimmune Dis       Date:  2012-02-22

8.  Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice.

Authors:  Aviva Katzav; Nikolaos C Grigoriadis; Tania Ebert; Olga Touloumi; Miri Blank; Chaim G Pick; Yehuda Shoenfeld; Joab Chapman
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

9.  16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus.

Authors:  Shaye Kivity; Aviva Katzav; Maria Teresa Arango; Moran Landau-Rabi; Yaron Zafrir; Nancy Agmon-Levin; Miri Blank; Juan-Manuel Anaya; Edna Mozes; Joab Chapman; Yehuda Shoenfeld
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

10.  Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.

Authors:  Rotem Inbar; Ronen Weiss; Lucija Tomljenovic; Maria-Teresa Arango; Yael Deri; Christopher A Shaw; Joab Chapman; Miri Blank; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.